|
US5674850A
|
|
High purity desmopressin produced in large single batches
|
|
WO9501368A1
|
|
Improved synthesis of cyclic peptides
|
|
WO9501183A1
|
|
Compositions for nasal administration of desmopressin
|
|
US5500413A
|
|
Process for manufacture of 1-deamino-8-D-arginine vasopressin
|
|
US5482931A
|
|
Stabilized pharmaceutical peptide compositions
|
|
CZ993A3
|
|
derivatives of neurohypophysis lobe hormones
|
|
CA2090859A1
|
|
Analogues of cyclolinopeptide a and the use thereof
|
|
AU8225191A
|
|
Derivatives of pituitary posterior lobe hormones
|
|
IL97298D0
|
|
Vasoactive vasotocin derivatives and pharmaceutical compositions containing them
|
|
IL96369D0
|
|
Decapeptide,monoclonal antibodies directed thereto and their use in diagnosis
|
|
CA2066721A1
|
|
Medicament comprising antamanide
|
|
WO9007523A1
|
|
Medicament comprising cyclolinopeptide a
|
|
EP0396559A1
|
|
Hiv peptides, artificial hiv antigens and immunoassay kits
|
|
AU2624288A
|
|
Hiv peptides, artificial hiv antigens and immunoassay kits
|
|
AU2533988A
|
|
Vasoactive peptides
|
|
AU7852887A
|
|
Topical radioprotective gel for mucosa
|
|
IE840275L
|
|
Renin inhibiting tetra-,penta or hexapeptide
|
|
WO8403044A1
|
|
Enzyme inhibitors
|
|
JPS59139350A
|
|
Vasotocin derivative
|
|
EP0112809A1
|
|
Vasotocin derivatives
|
